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ABSTRACT 
The expired nitric oxide (NO) concentration is known to be 
higher in asthmatic subjects than in normal subjects. To eluci-
date the role of NO in asthma, we examined the expired NO 
concentrations in relation to the type (atopic, mixed, non-
atopic), and severity (mild, moderate, severe) of asthmatics, 
as well as the influence of steroid treatment. Twenty-seven 
normal subjects, 48 asthmatics, 8 subjects with allergic rhini-
tis, and 13 subjects with pulmonary emphysema participated 
in the study. The expired NO concentration was significantly 
higher in asthmatics and patients with allergic rhinitis than in 
normal subjects (P<0.01). No significant difference was 
observed between the expired NO concentration in patients 
with pulmonary emphysema and that of normal subjects. The 
expired NO concentrations were significantly lower in non-
atopic asthma than in atopic asthma. Nitric oxide levels were 
significantly lower in severe asthma than in mild asthma. High 
doses of steroid treatment are often used in severe asthma. 
The dose of inhaled beclomethasone and expired NO con-
centrations showed a negative correlation (r=-0.51587, 
P<0.004). Drip infusion of hydrocortisone tended to increase 
the exhaled NO concentration just after drip infusion, how-
ever, it decreased after 24h. These results suggest that steroid 
treatment decreases the expired NO concentrations in asth-
matics, although it cannot be concluded that NO increases 
the severity of asthma. The measurement of expired NO con-
centrations is an easy, non-invasive test, which may be a use-
ful tool for monitoring the condition of asthmatics.
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INTRODUCTION 
Nitric oxide (NO) is known to be endogenously synthesized by 
nitric oxide synthase (NOS) of which there are three isoforms. In
the airway, NO is thought to be produced by inflammatory, 
endothelial and pulmonary epithelial cells and to have some 
relationship with several pulmonary diseases.1-3 Many investiga-
tors have reported on NO in the expired air of asthmatics. 
Persson et al. and Alving et al. demonstrated elevated NO levels 
in the expired air of asthmatics compared with normal subjects. 4,5 
In Japan, several investigators reported a high NO concentra-
tion in the expired air from asthmatics.6 Moreover, significantly 
lower NO concentrations have been reported in exhaled air from 
asthmatic patients with steroid treatment than from those without 
steroid treatment.7 On the contrary, Massaro et al. has sug-
gested the usefulness of NO in the treatment of asthma.8 But the 
role of NO in the mechanism of asthma is still unclear. 
  In this study, we examine NO levels in the expired air of adult 
asthmatics of various levels of severity, and investigate the rela-
tionship between NO levels and the type of asthma. We also 
evaluate the influence of steroid therapy on the expired NO 
concentration in asthmatics.
MATERIALS AND METHODS 
Subjects
Twenty-seven normal subjects, 48 adult asthmatics, 8 subjects 
with allergic rhinitis and 13 subjects with pulmonary emphysema 
participated in this study (Table 1). Normal subjects were defined 
as individuals with no significant history of pulmonary disease, 
cardiovascular disease or nasal disorder. Asthmatic subjects 
were selected from patients of the National Sanatorium of 
Minamiokayama Hospital. Diagnosis of these patients was con-
firmed by medical records of reversible airway obstruction and 
airway hypersensitivity. In asthmatics, one group (three males, 2 
females, mean age 40.0 years) received no regular treatment of 
steroid, and the other group (14 males, 29 females, mean age 
55.9 ears) received regular treatment of steroid (inhaled 
beclomethasone dipropionate or oral administration of pred-
nisolone). Allergic rhinitis subjects, defined as individuals with 
seasonal nasal discharge and obstruction, as well as high titres 
of IgE or pollen-specific IgE, included five patients with bronchial 
asthma. Four of these patients were treated with inhaled steroid
(100-600μg/day). Pulmonary emphysema subjects were all
male smokers or former smokers, defined as individuals with
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Fig. 1 Mixed expired NO concentrations in normal subjects (n=27), 
asthmatics (n=48), allergic rhinitis (n=8), and pulmonary emphysema 
(n=13). NO concentrations in asthmatics and subjects of allergic rhini-
tis were significantly higher than that in normal subjects. *P<0.01.
Table 1. Subjects participating in the study
both low attenuation areas in chest computed tomography (CT) 
and lower FEV 1.0% (below 70%). This group had a higher age 
population than the other disease groups. The study was 
approved by the hospital ethics committee and fully informed 
consents were obtained from all subjects participating.
Measurement of exhaled NO levels 
The NO level in mixed expired air from all subjects was mea-
sured using a chemiluminescence analyser (CLM-500, Shimazu 
Co. Ltd, Kyoto, Japan) sensitive to NO from 0.5ppb. This system 
does not require the collection of exhaled air in a reservoir, so 
the variable loss of NO can be avoided, resulting in greater sen-
sitivity. After flushing the analyser with NO-free compressed air, 
seated subjects wearing noseclips inhaled through the mouth for 
30s to total lung capacity and then expired the air, not forcibly, 
for 20s to residual volume. A 20s measurement was used in 
order to obtain a peak value. During continuous NO sampling, 
two successive recordings were performed, separated by a 60s 
rest-the mean of two values was used. Calibration was per-
formed after each patient's measurement. To exclude the effects 
of ambient NO concentration, the ambient NO levels were
Fig. 2 Expired NO concentrations in atopic, mixed and non-atopic 
asthma. Atopic asthma (n=10), mixed asthma (n=5) and non-atopic 
asthma (n=33). In atopic asthma, NO concentrations were significantly 
higher than that in non-atopic asthma. *P<0.055
recorded before each breath and results were corrected. The 
area under the concentration curve was highly correlated with 
the peak value,1 and peak values were used for evaluation.
Statistical analysis 
All mean expired NO concentrations are reported in ppb with 
the corresponding standard error of the mean. Mean expired 
NO concentrations were compared using ANOVA.
RESULTS
Figure 1 shows the mixed expired NO concentrations in normal 
subjects, asthmatics, patients with allergic rhinitis (including sub-
jects who have both asthma and allergic rhinitis and allergic rhini-
tis only) and patients with pulmonary emphysema. The mean
expired NO concentration in 27 normal subjects was 49.8±19.3
ppb. Among these normal subjects, the mixed expired NO con-
centration in individuals with a smoking history (six males, mean
age 34.0 years, range 19-53 years) was 46.7±16.9ppb, which
tended to be lower than the value (51.0±20.5ppb) in non-
smokers (7 males, 14 females, mean age 34.5 years, range 19-
61 years). In 48 asthmatics (non-smokers), the mean expired NO
concentration (193.9±126.2ppb) was significantly higher than
hat in normal subjects (P<0.01). Furthermore, the mean expired 
NO co centration in eight subjects with allergic rhinitis was
302,6±190.5ppb, much higher than that in normal subiects.
The mean mixed expired NO concentration in 13 pulmonary
emphysema subjects was 62.8±38.5ppb. There was, however,
no significant difference among normal subjects and subjects with 
pulmonary emphysema. Subjects with allergic rhinitis had a high
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Fig. 3 The estimate of expired NO concentration in severity of asthma. 
Mild asthma (n=10), moderate asthma (n=14) and severe asthma 
(n=23). Nitric oxide concentrations in mild asthma were significantly 
higher than that in severe asthma. *P<0.05.
concentration of expired NO. There was no difference between 
the expired NO concentration in subjects with both bronchial 
asthma and allergic rhinitis (n=5) and subjects with allergic rhini-
tis only (n=3) (data not shown). 
 The expired NO concentration among the asthma types was 
evaluated to clarify the role of NO in the mechanism of bronchial 
asthma. First, the expired NO concentration in the atopic group 
(n=10, six males, four females, mean age 34.8 years, range 
17-63 years), mixed group (n=5, three males, two females, 
mean age 47.6 years, range 36-61 years) and non-atopic group 
(n=33, 8 males, 25 females, mean age 58.8 years, range 40-75 
years) was measured. Concentrations in these three groups were
305.9±133.8, 216.3±161.8 and 173.9±121.4 ppb, respec-
tively (Fig. 2). There was a significant difference between the 
atopic and non-atopic asthma groups (P<0.05). 
  Second, concentrations were evaluated in relation to the sever-
ity of the asthma (Fig. 3). The standard of severity of asthma was 
as advocated by the Japanese Society of Allergology. 9 The mixed 
expired NO concentration in the mild asthma group (five males, 
five females, mean age 51.7 years, range 17-74 years), moder-
ate asthma group (six males, eight females, mean age 52.3 
years, range 17-74 years), and severe asthma group (6 males, 
18 females, mean age 53.4 years, range 27-75 years) was
268.1±128.0, 227.5±139.1 and 150.3±121.1 ppb, respec-
tively. The.expired NO concentration in the severe asthma group 
was significantly lower than that in mild asthma group (P<0.05). 
  Since steroid treatment was common in the severe asthma group, 
the low expired NO concentration in the severe asthma group may 
have resulted from steroid treatment. Therefore, we examined the 
relationship between NO concentration and steroid treatment (Fig. 
4a). Asthmatics with steroid treatment were included with two 
groups. One group (9 males, 14 females, mean age 53.6 years)
Fig. 4 (a) Correlation between the expired NO concentration and the 
inhaled beclomethasone therapy in asthmatics (n=29). The negative 
correlation was observed (r=-0.51587, P<0.004). Triangles show 
atopic asthmatics and circles non-atopic asthmatics. (b) The negative 
correlation in non-atopic type asthmatics between the expired NO con-
centration and the inhaled beclomethasone therapy (n=19, 
r=-0.48883, P<0.04).
received only regular inhaled beclomethasone treatment, and the 
other group (5 males, 15 females, mean age 58.2 years) received 
both oral administration of prednisolone (PO) and inhaled 
beclomethasone. Estimating the equivalent dose of PO to inhaled 
beclomethasone is difficult, although several evaluations have been 
reported. 10, 11 Therefore, only the group with inhaled beclometha-
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Fig. 5 Influence of drip infusion of hydrocortisone and aminophylline 
on expired NO concentration lust after drip infusion (n=11). Four sub-
lects were followed up 24h after drip infusion.
sone treatment was used in the correlation study between the 
expired NO concentration and the dose of steroid. Inhaled 
beclomethasone treatment and expired NO concentration in asth-
matics showed a negative correlation (r=-0.51587, P<0.004). In 
Fig. 4b, the NO concentration and inhaled beclomethasone 
showed a negative correlation in non-atopic asthmatics (n=19, 
r=-0.48883, P<0.04), but no significant correlation in atopic 
asthmatics (n=10), because of the small number of subjects. 
 Figure 5 shows the influence of drip infusion of hydrocorti-
sone (200μg) and aminophylline (125mg) administered
together. Nitric oxide concentration was 98.5±60.4ppb before
drip infusion and 122.7±80.1ppb just after drip infusion
(n=11). Unexpectedly, the expired NO concentration just after 
drip infusion was unchanged compared with that before drip 
infusion. Since drip infusion of aminophylline alone did not 
influence the NO concentration (data not shown, n=4), this 
phenomenon might be influenced by the drip infusion of hydro-
cortisone. Twenty-four hours after drip infusion, the expired NO 
concentration decreased. The NO concentration was
89.6±31.6ppb before drip infusion, 96.0±31.2ppb just after,
and 72.0±22.5ppb 24h after drip infusion (n=4).
DISCUSSION
In these studies, the expired NO concentrations in adult asthmat-
ics was measured and found to be consistent with previous 
reports,4-7 in that the expired NO concentration from asthmatics is 
higher than that from normal subjects. High NO concentrations in 
the expired air from patients with allergic rhinitis were also 
observed which confirms an earlier report on increased NO levels 
in seasonal and perennial allergic rhinitis.12 Martin et al. showed 
that nasal levels of NO in exhaled air were higher in symptomatic 
seasonal allergic rhinitis and perennial rhinitis than in normal sub-
jects even out of season.12 Kimberly et al. have recently shown that 
NO levels in nasal expired air are generally higher than those in 
oral expired air in human.13 This finding might account for the 
much higher levels of expired NO in allergic rhinitis. On the other 
hand, it is understandable that patients with pulmonary emphy-
sema showed lower NO levels than asthmatics because of the dif-
ferent disease mechanism. In the airway high NO concentrations 
are observed in allergic or non-allergic inflammation.14
 Patients who had both bronchial asthma and allergic rhinitis 
were excluded from the asthma group in order to avoid the influ-
ence of allergic rhinitis on the expired NO concentrations from 
asthmatics. Nevertheless, there was no significant difference 
between patients with asthma and allergic rhinitis and patients 
with allergic rhinitis only (data not shown). Both groups of patients 
had very high expired NO concentrations, however, since the 
number of patients was very small, further study with a larger 
number of patients must be performed to confirm that the differ-
ence was not significant between asthma and allergic rhinitis.
Results obtained indicated lower expired NO concentrations
in severe asthma than in mild asthma which suggests the influ-
ence of steroid treatment. Because high-dose beclomethasone
inhal tion therapy is common in moderate and severe adult
asthm tics, many patients with steroid treatment were included
in this study. Severe asthmatics tend to use higher steroid doses.
T erefor  high doses of steroid bring about low expired NO
concentration of severe asthmatics. In severe asthma, allergic
infl mmation is thought to cause small airway destruction. This
fa  may result in the low NO concentration in severe asthma by
destroying alveolar epithelium cells. Vessel epithelium cells pro-
duce a high concentration of NO, which should not affect the
expired NO concentration because the NO disappears rapidly
by binding to haemoglobin.
It is difficult to explain why the expired NO concentration was
higher in the atopic asthma group than in the non-atopic group.
One reason may be that a higher dose of steroid tends to be used
in non-atopic compared with atopic asthma (indicated in Fig. 4a). 
Atopic asthmatics with steroid therapy who participated in this 
stu y used only inhaled beclomethasone. Nineteen non-atopic 
asthmatics used inhaled only beclomethasone. But other 14 non-
atopic s hmatics and 5 mixed asthmatics used higher doses of 
steroid (inhaled beclomethasone and orally administered pre-
donisolone). The other reason may be the difference in the mech-
anism between atopic and non-atopic inflammation. It is more 
likely that the dose of steroid can explain the discrepancies in 
Figure 4a and b.
 The negative correlation between the dose of steroid adminis-
tered to patients and the expired NO concentrations may indicate 
hat steroid treatments reduce the expired NO concentration in 
asthmatics. Because equivalent doses of inhaled beclomethasone 
and oral administered PO could not be determined, we used only 
inhal  beclomethasone treatment. 
  Our results, that steroid treatment decreased the NO concen-
trations in asthmatics, are similar to those of other investiga-
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tors.7,8 The expression of immunoreactive inducible NOS (iNOS) 
was observed in airway epithelium from asthmatics but not from 
normal subjects.15 Kharitonov et al. suggested that induction of 
iNOS in asthmatic airways resulted in the high exhaled NO con-
centration. They also suggested that steroid treatment inhibits 
iNOS and results in a lower expired NO concentration from 
asthmatics. In fact, the induction of iNOS in macrophages, 
epithelial cells and inflammatory cells in airways was 
reported.1,16-18 It is possible that these iNOS are the source of 
NO in expired air. Our results about the influence of drip infu-
sion of steroid downregulating expired NO concentration, may 
be related to the fact that airway NO is produced from induced 
iNOS. Suppression of iNOS by steroid may occur several hours 
after drip infusion, thus the steroid influence may be observed 24 
h after drip infusion, not just after drip infusion. 
  Nevertheless, it is still unclear that NO is a causative factor in 
asthma. The negative correlation observed between steroid treat-
ment and the NO concentration in expired air from asthmatics 
may confirm the inhibitory effect of steroid, however, we found sev-
eral patients in good condition without steroid treatment and 
patients of allergic rhinitis showed a very high NO concentration. It 
is well known that NO is the neurotransmitter of bronchodilator 
nerves and relaxes human airway smooth muscles.19'20 We think 
the hypothesis that NO is a causative factor in asthma is incorrect. 
There are several new reports suggesting that NO has no effect on 
bronchoconstriction but rather on allergic inflammation. 
Histamine-induced bronchoconstriction does not provoke a rise in
exhaled NO levels in mild asthma.21 Inhalation of β2-agonists does
not alter the exhaled NO in asthma.22 Inhaled steroid seemed to 
reduce exhaled NO concentrations in asthmatic children in a 
dose-dependent fashion.23 However, as yet it cannot be concluded 
whether NO is a causative factor or a result of inflammation. 
  Measurement of expired NO concentrations is non-invasive 
and easy to perform, and expected to be a useful method to 
quickly determine the status of bronchial asthma. Nitric oxide 
levels appear to reflect inflammation rather than bronchocon-
striction, and seem to be suppressed by steroid. Further long-
term work is required to conclude that the NO concentration in 
expired air from bronchial asthma subjects indicates the type of 
bronchial asthma.
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